OBJECTIVE: The objectives of present study were to determine the frequency of early response (ER), defined as a 20% decrease in total baseline PANSS score at three weeks and to compare the rate of symptomatic and functional remission between schizophrenic adolescents with and without ER. METHODS: The sample included 61 patients (65% males) with a mean age of 15 (+ 1.54) y.o., 88.5% on their first episode of psychosis who were evaluated with PANSS and PSP scales y. They were evaluated with PANSS at week three and with PANSS and PSP at month six. RESULTS: Twenty-three patients (37.7%) showed ER. There were no significant differences in the rate of symptomatic or functional remission at month six between responders and non-responders. CONCLUSIONS: Early response to antipsychotic treatment can be observed in adolescent patients, however, it is not associated with remission at six months.
OBJECTIVE: The objectives of present study were to determine the frequency of early response (ER), defined as a 20% decrease in total baseline PANSS score at three weeks and to compare the rate of symptomatic and functional remission between schizophrenic adolescents with and without ER. METHODS: The sample included 61 patients (65% males) with a mean age of 15 (+ 1.54) y.o., 88.5% on their first episode of psychosis who were evaluated with PANSS and PSP scales y. They were evaluated with PANSS at week three and with PANSS and PSP at month six. RESULTS: Twenty-three patients (37.7%) showed ER. There were no significant differences in the rate of symptomatic or functional remission at month six between responders and non-responders. CONCLUSIONS: Early response to antipsychotic treatment can be observed in adolescent patients, however, it is not associated with remission at six months.
Entities:
Keywords:
adolescents; antipsychotic; early response; remission; schizophrenia
Authors: Juan A Gallego; Delbert G Robinson; Serge M Sevy; Barbara Napolitano; Joanne McCormack; Martin L Lesser; John M Kane Journal: J Clin Psychiatry Date: 2011-09-06 Impact factor: 4.384
Authors: David V Sheehan; Kathy H Sheehan; R Douglas Shytle; Juris Janavs; Yvonne Bannon; Jamison E Rogers; Karen M Milo; Saundra L Stock; Berney Wilkinson Journal: J Clin Psychiatry Date: 2010-03 Impact factor: 4.384
Authors: Marie Stentebjerg-Olesen; Stephen J Ganocy; Robert L Findling; Kiki Chang; Melissa P DelBello; John M Kane; Mauricio Tohen; Pia Jeppesen; Christoph U Correll Journal: Eur Child Adolesc Psychiatry Date: 2015-06-02 Impact factor: 4.785
Authors: Christoph U Correll; Joan Zhao; William Carson; Ron Marcus; Robert McQuade; Robert A Forbes; Raymond Mankoski Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-06-05 Impact factor: 8.829
Authors: A Fresán; C De la Fuente-Sandoval; C Loyzaga; M García-Anaya; N Meyenberg; H Nicolini; R Apiquian Journal: Schizophr Res Date: 2005-01-01 Impact factor: 4.939
Authors: Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner Journal: Brain Behav Date: 2021-05-15 Impact factor: 2.708